Progress in diagnosis and treatment of hepatic alveolar echinococcosis
10.3969/j.issn.1674-7445.2023257
- VernacularTitle:肝泡型包虫病的诊治进展
- Author:
Zhixin WANG
1
;
Yunfei LIU
1
;
Hao WANG
1
;
Haijiu WANG
1
;
Haining FAN
1
Author Information
1. Department of Hepatopancreatobiliary Surgery, Affiliated Hospital of Qinghai University, the Research Key Laboratory for Echinococcosis of Qinghai Province, Xining 810012, China.
- Publication Type:Editorial
- Keywords:
Hepatic alveolar echinococcosis;
Echinococcus multilocularis;
Shear wave elastography;
18F-fluorodeoxyglucose;
Positron emission tomography and computed tomography (PET-CT);
Hepatectomy;
Liver transplantation;
Albendazole
- From:
Organ Transplantation
2024;15(2):171-177
- CountryChina
- Language:Chinese
-
Abstract:
Hepatic echinococcosis is a chronic parasitic disease, which is caused by the larvae of Echinococcus multilocularis. It has a high risk of disability and mortality, which is also known as "parasite cancer". In clinical practice, hepatic echinococcosis can be divided into hepatic alveolar echinococcosis and hepatic cystic echinococcosis. Hepatic echinococcosis is widely prevalent worldwide. It mainly occurs in the populations residing agricultural and pastoral areas in western China, posing significant threats to the quality of life of local residents. At present, surgery is the main treatment for hepatic echinococcosis in clinical settings. With rapid development of surgical diagnosis and treatment technology and deepening understanding of hepatic echinococcosis, diagnosis and treatment regimens have also been constantly improved. In this article, research progresses on the diagnosis and treatment of hepatic alveolar echinococcosis were reviewed, aiming to provide reference for clinicians, deliver early diagnosis and treatment, mitigate adverse effects of this disease upon patients and improve clinical prognosis.
